Digital diary helps Fine-Tune blood pressure meds remotely
NCT ID NCT06372470
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a smartphone app and home blood pressure monitor could help doctors personalize the dose of the blood pressure drug Zestril for each patient without needing in-person visits. Twenty adults with uncomplicated high blood pressure participated. The goal was to see if this remote approach is practical and helps more patients reach their target blood pressure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
20 people
The number who actually took part.
- Started
-
Apr 2024
- Finished
-
Oct 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Uncomplicated primary hypertension cohort in England
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adults aged 18 years and older. 2. Patients diagnosed with uncomplicated essential (primary) hypertension eligible for Zestril per SmPC for hypertension management. 3. Participants must provide written informed consent to participate in the study, including agreeing to adhere to the study procedures. 4. Have access to and be able to use a suitable smartphone independently, running either iOS version 15 or later or Android version 10 or later. Exclusion Criteria: 1. Clinically significant abnormal blood results as judged by the investigator (exclude patients with known renal impairment). 2. History of clinically important medical conditions that would compromise a patient's ability to participate safely (including an allergic reaction to Zestril/lisinopril or any other medicine and/or other contraindications and interactions listed in Zestril's SmPC). 3. Patients with a strongly activated renin-angiotensin-aldosterone system (in particular, renovascular hypertension, salt and /or volume depletion, cardiac decompensation, or severe hypertension) as per SmPC 4. Participants who are unwilling or unable to participate in remote study procedures, including home BP monitoring, remote consultations, and data submission as judged by the investigator. 5. Any condition associated with poor compliance including alcoholism or drug dependence. 6. Participants with cognitive impairments or language barriers that hinder their ability to understand and comply with study instructions and e-questionnaires. 7. Failure to satisfy the investigator of fitness to participate for any other reason.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Uncomplicated hypertension are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Norwich Health Centre
Norwich, United Kingdom